Diagnostic value of high-risk HPV E6/E7 mRNA in patients with ASCUS

被引:1
作者
Jin, Xiu [1 ]
Liu, Feifei [1 ]
Zhang, Ya [2 ]
Ma, Yingying [3 ]
Yang, Linqing [3 ]
Wang, Yunfei [3 ]
Liu, Ying [3 ]
机构
[1] Jining Med Univ, Affiliated Hosp, Dept Pathol, Jining, Shandong, Peoples R China
[2] Jining Med Univ, Affiliated Hosp, Dept Obstet, Jining, Shandong, Peoples R China
[3] Jining Med Univ, Dept Gynecol, Affiliated Hosp, Jining, Shandong, Peoples R China
关键词
Cervical cancer; ASCUS; HPV E6/E7 mRNA; Menopause; Colposcope; CERVICAL-CANCER; PREVENTION; WOMEN; PERFORMANCE; POPULATION; LESIONS;
D O I
10.1186/s12905-023-02599-3
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective To investigate the infection status of high-risk human papillomavirus (HR-HPV) E6/E7 mRNA in patients with a cytological diagnosis of "atypical squamous cells of undetermined significance" (ASCUS) and to analyze the pathogenic rate of different high-risk HPV subtypes combined with biopsy pathological results to provide a more accurate basis for managing ASCUS patients.Methods A total of 1387 patients with ASCUS and HPV E6/E7 mRNA positivity who were referred for colposcopy were retrospectively analyzed. They were divided into HPV16+, 18/45 + and other HR-HPV + groups premenopausal and postmenopausal groups. The pathological results of the biopsy were divided into the LSIL- group (including normal and low-grade squamous intraepithelial lesions) and the HSIL + group (including high-grade squamous intraepithelial lesions and higher lesions). SPSS was used for the analysis.Results The age group 31-40 years had the highest level of HPV16+, and HPV18/45 + was the highest in the 41-50 years group. The detection rates of HSIL + in the HPV16+, HPV18/45+, HPV 16/18/45 + and Other HR-HPV + groups were 48.4%, 18.8%, 43.9% and 15.0%, respectively. The infection rates of HPV16/18/45 in postmenopausal and premenopausal women were 42.4% and 34.3%, respectively. In the HPV18/45 group, the incidence of HSIL + was 30.0% in postmenopausal women and 15.0% in premenopausal women (P < 0.01). In the HPV 16 + and Other HR-HPV + groups, the incidence of HSIL + in postmenopausal patients was not significantly different from that in premenopausal patients. The incidence of cervical cancer in postmenopausal patients is significantly higher than that in premenopausal patients.Conclusions Colposcopy referral or further biopsy is recommended for all ASCUS patients with HPV16/18/45E6/E7 mRNA positivity and postmenopausal patients with HR-HPVE6/E7 mRNA positivity. For premenopausal ASCUS patients with other HR-HPV E6/E7 mRNA positivity, colposcopy should be performed if possible, depending on the specific situation, to achieve early detection and diagnosis.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] High-risk HPV oncoproteins E6 and E7 and their interplay with the innate immune response: Uncovering mechanisms of immune evasion and therapeutic prospects
    Lo Cigno, Irene
    Calati, Federica
    Girone, Carlo
    Catozzo, Marta
    Gariglio, Marisa
    JOURNAL OF MEDICAL VIROLOGY, 2024, 96 (06)
  • [32] RETRACTED: Predictive Value of HPV E6/E7 mRNA Detection on the Outcome of Cervical LSIL (Retracted Article)
    Cao, Limei
    He, Ping
    Yang, Jun
    Long, Xin
    Chen, Yanqiu
    Yan, Li
    Zhou, Deping
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022
  • [33] Human papillomavirus (HPV) E6/E7 mRNA as a triage test after detection of HPV 16 and HPV 18 DNA
    Perez Castro, Sonia
    Inarrea Fernandez, Amparo
    Lamas Gonzalez, Maria Jose
    Saran Diez, Maria Teresa
    Cid Lama, Ana
    Alvarez Martin, Maria Jesus
    Pato Mosquera, Monica
    Lopez-Miragaya, Isabel
    Estevez, Nuria
    Torres Pinon, Julio
    Ona Navarro, Maria
    JOURNAL OF MEDICAL VIROLOGY, 2013, 85 (06) : 1063 - 1068
  • [34] Uniplex E6/E7 PCR method detecting E6 or E7 genes in 39 human papillomavirus types
    Okodo, Mitsuaki
    Okayama, Kaori
    Teruya, Koji
    Sasagawa, Toshiyuki
    JOURNAL OF MEDICAL VIROLOGY, 2018, 90 (05) : 981 - 988
  • [35] Diagnostic validity of human papillomavirus E6/E7 mRNA test in cervical cytological samples
    Liu, Tong-Yu
    Xie, Rong
    Luo, Li
    Reilly, Kathleen H.
    He, Cheng
    Lin, Yu-Zhen
    Chen, Gang
    Zheng, Xiong-Wei
    Zhang, Lu-Lu
    Wang, Hai-Bo
    JOURNAL OF VIROLOGICAL METHODS, 2014, 196 : 120 - 125
  • [36] Significance of HR-HPV E6/E7 mRNA detection to screen the severity of cervical cancer in relation to age
    Zhong, Ahong
    Wang, Huihui
    Zhang, Zhongfang
    Zheng, Yafeng
    Xia, Bairong
    Chen, Jiming
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2024, 45 (04) : 88 - 92
  • [37] A cohort retrospective study of high-risk HPV recurrence in Greek women after cervical lesion treatment through detection of viral E6/E7 mRNA expression
    Carcea, Fausto
    Daniilidis, Angelos
    Vavoulidis, Eleftherios
    Nasioutziki, Maria
    Papanikolaou, Alexios
    Dinas, Konstantinos
    JOURNAL OF BUON, 2020, 25 (01): : 99 - 107
  • [38] E6/E7 Sequence Diversity of High-Risk Human Papillomaviruses in Two Geographically Isolated Populations of French Guiana
    Nacher, Mathieu
    Godefroy, Gersande
    Dufit, Valentin
    Douine, Maylis
    Najioullah, Fatiha
    Cesaire, Raymond
    Thomas, Nadia
    Drak Alsibai, Kinan
    Adenis, Antoine
    Lacoste, Vincent
    MICROORGANISMS, 2020, 8 (11) : 1 - 17
  • [39] The application of PAX1 methylation detection and HPV E6/E7 mRNA detection in cervical cancer screening
    Li, Bijun
    Guo, Ruixia
    Lai, Tianjiao
    Qiao, Long
    Fu, Hanlin
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2021, 47 (08) : 2720 - 2728
  • [40] Quantification of HPV16 E6/E7 mRNA Spliced Isoforms Viral Load as a Novel Diagnostic Tool for Improving Cervical Cancer Screening
    Camus, Claire
    Vitale, Sebastien
    Loubatier, Celine
    Penaranda, Guillaume
    Khiri, Hacene
    Plauzolles, Anne
    Carcopino, Xavier
    Halfon, Philippe
    Giordanengo, Valerie
    JOURNAL OF CLINICAL MEDICINE, 2018, 7 (12)